Clearside Biomedical Inc (CLSD)
1.26
0.00 (0.00%)
USD |
NASDAQ |
May 01, 16:00
1.25
-0.01
(-0.79%)
After-Hours: 20:00
Clearside Biomedical Free Cash Flow (Quarterly): 0.375M for Dec. 31, 2023
Free Cash Flow (Quarterly) Chart
Historical Free Cash Flow (Quarterly) Data
Date | Value |
---|---|
December 31, 2023 | 0.375M |
September 30, 2023 | -6.52M |
June 30, 2023 | -6.436M |
March 31, 2023 | -7.331M |
December 31, 2022 | -5.698M |
September 30, 2022 | -6.341M |
June 30, 2022 | -5.443M |
March 31, 2022 | 3.871M |
December 31, 2021 | 5.054M |
September 30, 2021 | -3.278M |
June 30, 2021 | -6.95M |
March 31, 2021 | -5.559M |
December 31, 2020 | -4.436M |
September 30, 2020 | -2.661M |
June 30, 2020 | -3.22M |
March 31, 2020 | -2.858M |
December 31, 2019 | 1.689M |
September 30, 2019 | -6.047M |
Date | Value |
---|---|
June 30, 2019 | -10.06M |
March 31, 2019 | -12.67M |
December 31, 2018 | -24.31M |
September 30, 2018 | -19.75M |
June 30, 2018 | -19.57M |
March 31, 2018 | -15.65M |
December 31, 2017 | -15.09M |
September 30, 2017 | -13.45M |
June 30, 2017 | -11.56M |
March 31, 2017 | -11.29M |
December 31, 2016 | -6.456M |
September 30, 2016 | -6.377M |
June 30, 2016 | -5.483M |
March 31, 2016 | -4.396M |
December 31, 2015 | -3.853M |
September 30, 2015 | -3.151M |
June 30, 2015 | -3.182M |
March 31, 2015 | -3.748M |
Free Cash Flow Definition
Free cash flow measures the amount of cash left over from a time period after all operational and working capital payments are made. Free cash flow is an important metric because it allows you to view the amount actual cash is available to the company. Free cash flow is also commonly used in valuation calculations like the discounted cash flow valuation model.
Free Cash Flow (Quarterly) Range, Past 5 Years
-10.06M
Minimum
Jun 2019
5.054M
Maximum
Dec 2021
-3.782M
Average
-5.443M
Median
Jun 2022
Free Cash Flow (Quarterly) Benchmarks
Cassava Sciences Inc | -22.36M |
Heron Therapeutics Inc | 2.205M |
Actinium Pharmaceuticals Inc | -7.385M |
Karyopharm Therapeutics Inc | -18.58M |
Ocular Therapeutix Inc | -22.91M |